Skip to main content
. Author manuscript; available in PMC: 2016 May 9.
Published in final edited form as: Biochem J. 2010 Jul 15;429(2):391–401. doi: 10.1042/BJ20100336

Figure 2. VTVs utilize Sec22b as a functional v-SNARE to fuse with hepatic cis-Golgi.

Figure 2

VTVs (150 μg of protein) containing [14C]TAG and [3H]apoB100 were incubated at 4 °C with 10 μl of pre-immune IgG, 10 μl of anti-Sec22b antibodies, 10 μl of anti-VAMP7 antibodies, 10 μl of anti-Sar1 antibodies or 10 μl of boiled anti-Sec22b antibodies. Antibodies in each case were removed by washing, and the treated VTVs were incubated with non-radiolabelled cis-Golgi (300 μg of protein) at 37 °C in the presence or absence (no cyto) of cytosol (0.5 mg of protein). (A) After incubation, Golgi membranes were separated and the Golgi-associated [14C]TAG was extracted (A) or the Golgi-associated [3H]apoB100 was immunoprecipitated (B). Total [14C]TAG (A) or [3H]apoB100 (B) levels (in d.p.m.) were determined. For details, see the Experimental section. Results are means + S.E.M. (n = 4).